Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Forward Defense, LLC, St. Louis, MO, USA.
Nat Commun. 2024 Oct 8;15(1):8702. doi: 10.1038/s41467-024-52714-7.
Staphylococcus aureus remains a leading global cause of bacterial infection-associated mortality and has eluded prior vaccine development efforts. S. aureus α-toxin (Hla) is an essential virulence factor in disease, impairing the T cell response to infection. The anti-Hla antibody response is a correlate of human protective immunity. Here we observe that this response is limited early in human life and design a vaccine strategy to elicit immune protection against Hla in a neonatal mice. By targeted disruption of the interaction of Hla with its receptor ADAM10, we identify a vaccine antigen (Hla, Hla) that elicits an ~100-fold increase in the neutralizing anti-Hla response. Immunization with Hla enhances the T follicular helper (T) cell response to S. aureus infection, correlating with the magnitude of the neutralizing anti-toxin response and disease protection. Furthermore, maternal Hla immunization confers protection to offspring. Together, these findings illuminate a path for S. aureus vaccine development at the maternal-infant interface.
金黄色葡萄球菌仍然是全球细菌性感染相关死亡率的主要原因,并且逃避了之前的疫苗开发工作。金黄色葡萄球菌α-毒素(Hla)是疾病中的一种重要毒力因子,可损害感染时的 T 细胞反应。抗 Hla 抗体反应是人类保护性免疫的相关因素。在这里,我们观察到这种反应在人类生命的早期受到限制,并设计了一种疫苗策略,以在新生小鼠中引起针对 Hla 的免疫保护。通过靶向破坏 Hla 与其受体 ADAM10 的相互作用,我们确定了一种疫苗抗原(Hla,Hla),可使中和抗 Hla 反应增加约 100 倍。用 Hla 免疫接种可增强金黄色葡萄球菌感染时滤泡辅助性 T 细胞(Tfh)的反应,与中和抗毒素反应的程度和疾病保护相关。此外,母体 Hla 免疫接种可赋予后代保护。总之,这些发现为在母婴界面开发金黄色葡萄球菌疫苗指明了道路。